{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:56:01Z","timestamp":1791122161133,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Alzheimer's Research UK"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["U01 AG024904"],"award-info":[{"award-number":["U01 AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["P30 AG010129"],"award-info":[{"award-number":["P30 AG010129"]}]},{"name":"NIH","award":["K01 AG030514"],"award-info":[{"award-number":["K01 AG030514"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.neurobiolaging.2012.03.010","type":"journal-article","created":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T22:08:07Z","timestamp":1334700487000},"page":"73-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers"],"prefix":"10.1016","volume":"34","author":[{"given":"Manja","family":"Lehmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther L.","family":"Koedam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Barkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike P.","family":"Wattjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Scheltens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick C.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ana.410380414","article-title":"Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease","volume":"38","author":"Arai","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer's disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","article-title":"Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?","volume":"26","author":"Blennow","year":"1995","journal-title":"Mol. Chem. Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib6","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1212\/01.WNL.0000055847.17752.E6","article-title":"Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease?","volume":"60","author":"Ch\u00e9telat","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jalz.2010.12.010","article-title":"Impact of apolipoprotein \u03f54-cerebrospinal fluid beta-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment","volume":"7","author":"Chiang","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neurobiolaging.2005.07.003","article-title":"Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment","volume":"27","author":"de Leon","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib9","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1212\/01.wnl.0000256697.20968.d7","article-title":"Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease","volume":"68","author":"Devanand","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib10","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/brain\/awm016","article-title":"Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia","volume":"130","author":"Du","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib12","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib13","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3174\/ajnr.A1059","article-title":"Morphometric changes in the episodic memory network and tau pathologic features correlate with memory performance in patients with mild cognitive impairment","volume":"29","author":"Fjell","year":"2008","journal-title":"AJNR Am. J. Neuroradiol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1212\/01.wnl.0000287091.57376.65","article-title":"Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment","volume":"70","author":"Fleisher","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib16","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/brain\/awl377","article-title":"The topography of grey matter involvement in early and late onset Alzheimer's disease","volume":"130","author":"Frisoni","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exger.2009.10.010","article-title":"Total and phosphorylated tau protein as biological markers of Alzheimer's disease","volume":"45","author":"Hampel","year":"2010","journal-title":"Exp. Gerontol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib18","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1001\/archneur.62.5.770","article-title":"Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease","volume":"62","author":"Hampel","year":"2005","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.expneurol.2009.09.024","article-title":"Biological markers of amyloid beta-related mechanisms in Alzheimer's disease","volume":"223","author":"Hampel","year":"2010","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib21","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","article-title":"Alzheimer disease in the US population: prevalence estimates using the 2000 census","volume":"60","author":"Hebert","year":"2003","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02988444","article-title":"PET studies in dementia","volume":"17","author":"Herholz","year":"2003","journal-title":"Ann. Nucl. Med"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib23","first-page":"333","article-title":"Voxel-based morphometric comparison between early- and late-onset mild Alzheimer's disease and assessment of diagnostic performance of Z score images","volume":"26","author":"Ishii","year":"2005","journal-title":"AJNR Am. J. Neuroradiol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib24","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmri.21049","article-title":"The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods","volume":"27","author":"Jack","year":"2008","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib26","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.52.7.1397","article-title":"Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment","volume":"52","author":"Jack","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/archneur.63.5.674","article-title":"Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia","volume":"63","author":"Jicha","year":"2006","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib28","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/cercor\/bhj105","article-title":"Differential regional atrophy of the cingulate gyrus in Alzheimer disease: A volumetric MRI study","volume":"16","author":"Jones","year":"2006","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib29","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00234-007-0269-2","article-title":"Precuneus atrophy in early-onset Alzheimer's disease: A morphometric structural MRI study","volume":"49","author":"Karas","year":"2007","journal-title":"Neuroradiology"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib30","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1212\/WNL.58.8.1188","article-title":"MRI measures of entorhinal cortex versus hippocampus in preclinical AD","volume":"58","author":"Killiany","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib31","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1007\/s00330-011-2205-4","article-title":"Visual assessment of posterior atrophy development of a MRI rating scale","volume":"21","author":"Koedam","year":"2011","journal-title":"Eur. Radiol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/01.WNL.0000133114.92694.93","article-title":"Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment","volume":"63","author":"Korf","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib33","doi-asserted-by":"crossref","first-page":"627.e1","DOI":"10.1016\/j.neurobiolaging.2011.04.003","article-title":"Posterior cerebral atrophy in the absence of medial temporal lobe atrophy in pathologically confirmed Alzheimer's disease","volume":"33","author":"Lehmann","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib34","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/archneur.62.9.1410","article-title":"Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias","volume":"62","author":"Likeman","year":"2005","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archneur.63.1.38","article-title":"Neuropathologic substrate of mild cognitive impairment","volume":"63","author":"Markesbery","year":"2006","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archneur.58.3.397","article-title":"Mild cognitive impairment represents early-stage Alzheimer disease","volume":"58","author":"Morris","year":"2001","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib37","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1212\/01.WNL.0000147469.18313.3B","article-title":"MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET","volume":"63","author":"Mosconi","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ana.10669","article-title":"Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment","volume":"54","author":"Nestor","year":"2003","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib39","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1212\/WNL.56.9.1133","article-title":"Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review)","volume":"56","author":"Petersen","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib40","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and \u201cpreclinical\u201d Alzheimer's disease","volume":"45","author":"Price","year":"1999","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib41","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1073\/pnas.052587399","article-title":"Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI","volume":"99","author":"Scahill","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib42","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/BF00868807","article-title":"Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability","volume":"242","author":"Scheltens","year":"1995","journal-title":"J. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib43","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","article-title":"Atrophy of medial temporal lobes on MRI in probable Alzheimer's disease and normal aging\u2014Diagnostic value and neuropsychological correlates","volume":"55","author":"Scheltens","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000117417","article-title":"Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging","volume":"37","author":"Scheltens","year":"1997","journal-title":"Eur. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib45","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/awp007","article-title":"MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers","volume":"132","author":"Schuff","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000151241","article-title":"Different atrophic patterns in early- and late-onset Alzheimer's disease and evaluation of clinical utility of a method of regional z-score analysis using voxel-based morphometry","volume":"26","author":"Shiino","year":"2008","journal-title":"Dement. Geriatr. Cogn. Disord"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib48","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1212\/01.WNL.0000079053.77227.14","article-title":"Changes in premorbid brain volume predict Alzheimer's disease pathology","volume":"61","author":"Silbert","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pscychresns.2010.12.001","article-title":"Association between cerebrospinal fluid tau and brain atrophy is not related to clinical severity in the Alzheimer's disease continuum","volume":"192","author":"Sole-Padulles","year":"2011","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib50","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","article-title":"CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study","volume":"60","author":"Strozyk","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib51","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain","volume":"66","author":"Tapiola","year":"2009","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib52","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1097\/00001756-199712220-00022","article-title":"The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease","volume":"8","author":"Tapiola","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib53","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.neurobiolaging.2010.04.030","article-title":"Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study","volume":"31","author":"Tosun","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib54","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1474-4422(10)70306-9","article-title":"Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE \u03f54 allele","volume":"10","author":"van der Flier","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib55","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e3181af79fb","article-title":"MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change","volume":"73","author":"Vemuri","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib56","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1148\/radiol.2531082262","article-title":"Diagnostic imaging of patients in a memory clinic: Comparison of MR imaging and 64-detector row CT","volume":"253","author":"Wattjes","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib57","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/01.wnl.0000324924.91351.7d","article-title":"MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study","volume":"71","author":"Whitwell","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2012.03.010_bib58","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1212\/01.wnl.0000280575.77437.a2","article-title":"MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment","volume":"70","author":"Whitwell","year":"2008","journal-title":"Neurology"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458012002175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458012002175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:19:25Z","timestamp":1759317565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458012002175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0197458012002175"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.03.010","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}